|
1
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: A small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar :
|
|
2
|
Natarajan J, Hunter K, Mutalik VS and
Radhakrishnan R: Overexpression of S100A4 as a biomarker of
metastasis and recurrence in oral squamous cell carcinoma. J Appl
Oral Sci. 22:426–433. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Liu Z, Xu C, Chen Y, Zhang J, Cui B,
Chen X, An G, She X, Liu H, et al: Overexpression of S100A4 is
closely associated with the progression and prognosis of gastric
cancer in young patients. Oncol Lett. 5:1485–1490. 2013.PubMed/NCBI
|
|
4
|
Niu Y, Wang L, Cheng C, Du C, Lu X, Wang G
and Liu J: Increased expressions of SATB1 and S100A4 are associated
with poor prognosis in human colorectal carcinoma. APMIS.
123:93–101. 2015. View Article : Google Scholar
|
|
5
|
Zhang K, Zhang M, Zhao H, Yan B, Zhang D
and Liang J: S100A4 regulates motility and invasiveness of human
esophageal squamous cell carcinoma through modulating the AKT/Slug
signal pathway. Dis Esophagus. 25:731–739. 2012. View Article : Google Scholar
|
|
6
|
Wang L, Wang X, Liang Y, Diao X and Chen
Q: S100A4 promotes invasion and angiogenesis in breast cancer
MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Acta
Biochim Pol. 59:593–598. 2012.
|
|
7
|
Che P, Yang Y, Han X, Hu M, Sellers JC,
Londono-Joshi AI, Cai GQ, Buchsbaum DJ, Christein JD, Tang Q, et
al: S100A4 promotes pancreatic cancer progression through a dual
signaling pathway mediated by Src and focal adhesion kinase. Sci
Rep. 5:84532015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hua J, Chen D, Fu H, Zhang R, Shen W, Liu
S, Sun K and Sun X: Short hairpin RNA-mediated inhibition of S100A4
promotes apoptosis and suppresses proliferation of BGC823 gastric
cancer cells in vitro and in vivo. Cancer Lett. 292:41–47. 2010.
View Article : Google Scholar
|
|
9
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Larzabal L, El-Nikhely N, Redrado M,
Seeger W, Savai R and Calvo A: Differential effects of drugs
targeting cancer stem cell (CSC) and non-CSC populations on lung
primary tumors and metastasis. PLoS One. 8:e797982013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ping YF and Bian XW: Consice review:
Contribution of cancer stem cells to neovascularization. Stem
Cells. 29:888–894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liao J, Qian F, Tchabo N,
Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB,
Morrison CD, et al: Ovarian cancer spheroid cells with stem
cell-like properties contribute to tumor generation, metastasis and
chemotherapy resistance through hypoxia-resistant metabolism. PLoS
One. 9:e849412014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI,
Lin SC, Liu CJ, Hu WY and Yu YH: The epithelial-mesenchymal
transition mediator S100A4 maintains cancer-initiating cells in
head and neck cancers. Cancer Res. 71:1912–1923. 2011. View Article : Google Scholar
|
|
15
|
Liu Z, Liu H, Pan H, Du Q and Liang J:
Clinicopathological significance of S100A4 expression in human
hepatocellular carcinoma. J Int Med Res. 41:457–462. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang H, Zhao K, Yu Q, Wang X, Song Y and
Li R: Evaluation of plasma and tissue S100A4 protein and mRNA
levels as potential markers of metastasis and prognosis in clear
cell renal cell carcinoma. J Int Med Res. 40:475–485. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang YY, Ye ZY, Zhao ZS, Tao HQ and Chu
YQ: High-level expression of S100A4 correlates with lymph node
metastasis and poor prognosis in patients with gastric cancer. Ann
Surg Oncol. 17:89–97. 2010. View Article : Google Scholar
|
|
18
|
Shen W, Chen D, Fu H, Liu S, Sun K and Sun
X: S100A4 protects gastric cancer cells from anoikis through
regulation of αv and α5 integrin. Cancer Sci. 102:1014–1018. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen D, Zhang R, Shen W, Fu H, Liu S, Sun
K and Sun X: RPS12-specific shRNA inhibits the proliferation,
migration of BGC823 gastric cancer cells with S100A4 as a
downstream effector. Int J Oncol. 42:1763–1769. 2013.
|
|
20
|
Saleem M, Kweon MH, Johnson JJ, Adhami VM,
Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw
S, et al: S100A4 accelerates tumorigenesis and invasion of human
prostate cancer through the transcriptional regulation of matrix
metalloproteinase 9. Proc Natl Acad Sci USA. 103:14825–14830. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang L, Xu Y, Cai G, Guan Z and Cai S:
Downregulation of S100A4 expression by RNA interference suppresses
cell growth and invasion in human colorectal cancer cells. Oncol
Rep. 27:917–922. 2012.
|
|
22
|
Ochiya T, Takenaga K and Endo H: Silencing
of S100A4, a metastasis-associated protein, in endothelial cells
inhibits tumor angiogenesis and growth. Angiogenesis. 17:17–26.
2014. View Article : Google Scholar :
|
|
23
|
Bootcov MR, Bauskin AR, Valenzuela SM,
Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor
K, et al: MIC-1, a novel macrophage inhibitory cytokine, is a
divergent member of the TGF-beta superfamily. Proc Natl Acad Sci
USA. 94:11514–11519. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li PX, Wong J, Ayed A, Ngo D, Brade AM,
Arrowsmith C, Austin RC and Klamut HJ: Placental transforming
growth factor-beta is a downstream mediator of the growth arrest
and apoptotic response of tumor cells to DNA damage and p53
overexpression. J Biol Chem. 275:20127–20135. 2000. View Article : Google Scholar
|
|
25
|
Hromas R, Hufford M, Sutton J, Xu D, Li Y
and Lu L: PLAB, a novel placental bone morphogenetic protein.
Biochim Biophys Acta. 1354:40–44. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bauskin AR, Brown DA, Junankar S, Rasiah
KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ,
et al: The propeptide mediates formation of stromal stores of
PROMIC-1: Role in determining prostate cancer outcome. Cancer Res.
65:2330–2336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Welsh JB, Sapinoso LM, Kern SG, Brown DA,
Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, et
al: Large-scale delineation of secreted protein biomarkers
overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA.
100:3410–3415. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paralkar VM, Vail AL, Grasser WA, Brown
TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA and Thompson DD:
Cloning and characterization of a novel member of the transforming
growth factor-beta/bone morphogenetic protein family. J Biol Chem.
273:13760–13767. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yin T, Cho SJ and Chen X: RNPC1, an
RNA-binding protein and a p53 target, regulates macrophage
inhibitory cytokine-1 (MIC-1) expression through mRNA stability. J
Biol Chem. 288:23680–23686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wiklund FE, Bennet AM, Magnusson PK,
Eriksson UK, Lindmark F, Wu L, Yaghoutyfam N, Marquis CP, Stattin
P, Pedersen NL, et al: Macrophage inhibitory cytokine-1 (MIC-1/
GDF15): A new marker of all-cause mortality. Aging Cell.
9:1057–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Staff AC, Trovik J, Eriksson AG, Wik E,
Wollert KC, Kempf T and Salvesen HB: Elevated plasma growth
differentiation factor-15 correlates with lymph node metastases and
poor survival in endometrial cancer. Clin Cancer Res. 17:4825–4833.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schiegnitz E, Kämmerer PW, Koch FP, Krüger
M, Berres M and Al-Nawas B: GDF 15 as an anti-apoptotic, diagnostic
and prognostic marker in oral squamous cell carcinoma. Oral Oncol.
48:608–614. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsui KH, Chang YL, Feng TH, Chung LC, Lee
TY, Chang PL and Juang HH: Growth differentiation factor-15
upregulates interleukin-6 to promote tumorigenesis of prostate
carcinoma PC-3 cells. J Mol Endocrinol. 49:153–163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grigorian M, Andresen S, Tulchinsky E,
Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N,
Christensen A, Selivanova G, et al: Tumor suppressor p53 protein is
a new target for the metastasis-associated Mts1/S100A4 protein:
Functional consequences of their interaction. J Biol Chem.
276:22699–22708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan M, Wang Y, Guan K and Sun Y:
PTGF-beta, a type beta transforming growth factor (TGF-beta)
superfamily member, is a p53 target gene that inhibits tumor cell
growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA.
97:109–114. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Osada M, Park HL, Park MJ, Liu JW, Wu G,
Trink B and Sidransky D: A p53-type response element in the GDF15
promoter confers high specificity for p53 activation. Biochem
Biophys Res Commun. 354:913–918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baek SJ, Horowitz JM and Eling TE:
Molecular cloning and characterization of human nonsteroidal
anti-inflammatory drug-activated gene promoter. Basal transcription
is mediated by Sp1 and Sp3. J Biol Chem. 276:33384–33392. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baek SJ, Kim JS, Moore SM, Lee SH,
Martinez J and Eling TE: Cyclooxygenase inhibitors induce the
expression of the tumor suppressor gene EGR-1, which results in the
up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol.
67:356–364. 2005. View Article : Google Scholar
|
|
39
|
Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH,
Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, et al: Macrophage
inhibitory cytokine-1 induces the invasiveness of gastric cancer
cells by up-regulating the urokinase-type plasminogen activator
system. Cancer Res. 63:4648–4655. 2003.PubMed/NCBI
|
|
40
|
Baek KE, Yoon SR, Kim JT, Kim KS, Kang SH,
Yang Y, Lim JS, Choi I, Nam MS, Yoon M, et al: Upregulation and
secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric
cancers. Clin Chim Acta. 401:128–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Blanco-Calvo M, Tarrío N, Reboredo M,
Haz-Conde M, García J, Quindós M, Figueroa A, Antón-Aparicio L,
Calvo L and Valladares-Ayerbes M: Circulating levels of GDF15, MMP7
and miR-200c as a poor prognostic signature in gastric cancer.
Future Oncol. 10:1187–1202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tanno T, Lim Y, Wang Q, Chesi M, Bergsagel
PL, Matthews G, Johnstone RW, Ghosh N, Borrello I, Huff CA, et al:
Growth differentiating factor 15 enhances the tumor-initiating and
self-renewal potential of multiple myeloma cells. Blood.
123:725–733. 2014. View Article : Google Scholar :
|
